Literature DB >> 9681783

The role of endothelin-1 as a mediator of the pressure response after air embolism in blood perfused lungs.

J Schmeck1, T Koch, B Patt, A Heller, H Neuhof, K van Ackern.   

Abstract

OBJECTIVE: It is well known that lung embolism is associated with an increase in pulmonary vascular resistance. Since the mechanisms of pulmonary vascular reactions during embolism are still unclear, the aim of this study was to investigate the potential involvement of endothelin-1 (ET-1) and thromboxane A2 (TXA2) as mediators of the pulmonary artery pressure (PAP) increase after embolism using the selective ETA receptor antagonist LU135252 [1], the ETB receptor antagonist BQ788 [2], and the cyclooxygenase inhibitor diclofenac.
DESIGN: Prospective experimental study in rabbits.
SETTING: Experimental laboratory in a university teaching hospital.
SUBJECTS: 36 adult rabbits of either sex.
INTERVENTIONS: The experiments were performed in 36 isolated and ventilated rabbit lungs which were perfused with a buffer solution containing 10% of autologous blood. Embolism was induced by the injection of 0.75 ml air into the pulmonary artery. MEASUREMENTS AND
RESULTS: PAP and lung weight, reflecting edema formation, were continuously recorded. Perfusate samples were drawn intermittently to determine TXA2 and ET-1 concentrations. Air injection resulted in an immediate increase in PAP up to 22.8 +/- 1.4 mm Hg at 2.5 min (control, n = 6), which was parallelled by an enhanced generation of TXA2. No relevant edema formation occurred during the observation period. Pretreatment with the ETA receptor antagonist LU135252 significantly reduced the pressure reaction after air embolism (p < 0.001) whereas the ETB receptor antagonist BQ788 (n = 6) was without marked effects. The administration of diclofenac (n = 6) did not alter the PAP increase 2.5 min after embolism, but significantly reduced the pressure reaction during the further observation period (p < 0.001). The application of LU135252 and diclofenac together (n = 6) also significantly reduced the PAP increase from 2.5 min during the total observation period (p < 0.001).
CONCLUSIONS: The acute pressure reaction after air embolism is mainly mediated via ET-1 by an ETA receptor related mechanism. TXA2 seems to maintain this reaction for a longer time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681783     DOI: 10.1007/s001340050622

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

1.  Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases.

Authors:  W C Sessa; S Kaw; A Zembowicz; E Anggård; M Hecker; J R Vane
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

2.  Endothelin-1 and atrial natriuretic peptide in septic shock.

Authors:  C Mitaka; Y Hirata; K Makita; T Nagura; Y Tsunoda; K Amaha
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

3.  Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit.

Authors:  C Thiemermann; P S Lidbury; G R Thomas; J R Vane
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

4.  Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.

Authors:  I Macquin-Mavier; M Levame; N Istin; A Harf
Journal:  J Pharmacol Exp Ther       Date:  1989-08       Impact factor: 4.030

5.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

6.  Contribution of endothelin-1 to warm ischemia/reperfusion injury of the rat lung.

Authors:  M Okada; C Yamashita; M Okada; K Okada
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

7.  Characterization of serine protease-derived metabolites of big endothelin in the cytosolic fraction from human polymorphonuclear leukocytes.

Authors:  S Kaw; M Hecker; G J Southan; T D Warner; J R Vane
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

8.  Cardiopulmonary effects of endothelin-1 in the guinea pig: role of thromboxane A2.

Authors:  P del Basso; L Argiolas
Journal:  J Cardiovasc Pharmacol       Date:  1995       Impact factor: 3.105

9.  Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery.

Authors:  T Fukuroda; S Ozaki; M Ihara; K Ishikawa; M Yano; M Nishikibe
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

10.  Endothelin receptor subtypes in human versus rabbit pulmonary arteries.

Authors:  T Fukuroda; M Kobayashi; S Ozaki; M Yano; T Miyauchi; M Onizuka; Y Sugishita; K Goto; M Nishikibe
Journal:  J Appl Physiol (1985)       Date:  1994-05
View more
  5 in total

1.  Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism.

Authors:  K F Nilsson; L E Gustafsson; L C Adding; D Linnarsson; P Agvald
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

Review 2.  Gas exchange and pulmonary hypertension following acute pulmonary thromboembolism: has the emperor got some new clothes yet?

Authors:  John Y C Tsang; James C Hogg
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

3.  Effects of aspirin on the expression of nuclear factor-κB in a rat model of acute pulmonary embolism.

Authors:  Ling-Cong Wang; Rong-Lin Jiang; Wei Zhang; Li-Ling Wei; Ru-Hui Yang
Journal:  World J Emerg Med       Date:  2014

4.  Estimation of endothelin-mediated vasoconstriction in acute pulmonary thromboembolism.

Authors:  John Y C Tsang; Wayne J E Lamm
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

5.  Endothelin ETA receptors predominate in chronic thromboembolic pulmonary hypertension.

Authors:  Mark Southwood; Robert V MacKenzie Ross; Rhoda E Kuc; Guy Hagan; Karen K Sheares; David P Jenkins; Martin Goddard; Anthony P Davenport; Joanna Pepke-Zaba
Journal:  Life Sci       Date:  2016-02-10       Impact factor: 5.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.